This announcement is a separate document:
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Kucinski Keith A
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.